Quarterly ResultJul 28, 2026, 06:08 AM
Centene Q2 Adj. EPS $2.51; Raises 2026 Adj. EPS Guidance to >$4.80
AI Summary
Centene Corporation reported strong second-quarter 2026 financial results, with GAAP diluted EPS of $2.19 and Adjusted diluted EPS of $2.51. The company also raised its full-year 2026 GAAP diluted EPS guidance to greater than $3.11 and Adjusted diluted EPS guidance to greater than $4.80, citing underlying business strength and non-recurring items. Additionally, the company announced a change to its Board of Directors, with Kenneth Burdick resigning and Paul Diaz being appointed as a new director.
Key Highlights
- Q2 2026 GAAP diluted EPS was $2.19.
- Q2 2026 Adjusted diluted EPS was $2.51.
- Increased 2026 GAAP diluted EPS guidance to greater than $3.11.
- Increased 2026 Adjusted diluted EPS guidance to greater than $4.80.
- Total revenues for Q2 2026 reached $53.58 billion.
- Health benefits ratio (HBR) improved to 89.6% in Q2 2026 from 93.0% in Q2 2025.
- Director Kenneth Burdick resigned from the Board, effective July 28, 2026.
- Paul Diaz was elected to the Board, effective July 28, 2026, joining the Audit and Quality and Compliance Committees.
Price Impact
More from CNC